“Senolytic Therapeutics: Translating a Compelling Mouse Phenotype Into a Testable Human Endpoint”. Translational Medicine & Therapeutics Journal 2, no. 1 (February 7, 2023): 10–18. Accessed November 5, 2026. https://inkwise.org/index.php/TMTJ/article/view/78.